We are pleased to announce the six emerging startups chosen to participate in the #MassBioDrive Fall 2022 Cohort: AdductNE, @HDAXtx, @HybridexBio, Jenthera Therapeutics Inc., Orion, and pacDNA https://t.co/UphT6uhMFE
Super excited to be selected as an ALPHA startup at @CollisionHQ! Come check us out at Booth A1102 tomorrow (Tuesday, June 21st 2022) to learn more about how @HDAXtx is designing a targeted therapeutic platform for unmet healthcare needs. #Collision2022
On March 24, H2i's FemSTEM series wrapped up with the 2022 Pitch Competition!
We would like to congratulate our grand prize winner @RebeccaGAllan of @SciVance, 1st runner up @NabanitaNawar of @HDAXtx, and 2nd runner up, Jennifer Doucet of Glusyn Diagnostics! 🥳
H2i's FemSTEM 2022 Pitch Competition is happening on Thursday March 24th from 3:00-5:00 PM EST! To register: https://t.co/km4KyTYMKT Leading up to the event, we will be introducing you to our six incredible finalists.
Meet @NabanitaNawar, PhD candidate and co-founder of @HDAXtx
Tune in to show your support at the U of T Entrepreneurship Startup Prize pitch competition on March 7th at 2 pm. Visit https://t.co/MM5txxUjgl to register. #UofTStartupPrize
We have been selected for the Emerging Companies Forum at the 18th Annual BIOTECanada Investor Summit. Thank you @BIOTECanada and @adMare_Bio for the exciting opportunity!
We're excited to welcome @ABOzymes, Cura Therapeutics, Damona pharma & @HDAXtx, the companies selected to present at our Emerging Co.'s Forum at @BIOTECanada's upcoming Investor Summit. adMare is all about building companies, and these 4 are ones to watch!https://t.co/RbNMvJCBs7
The #BioTEC2021 pitch competition was a huge success! Thank you to the pitch competition teams, panel of VC judges, industry mentors, and sponsors!
* 1st: Epiloid
* 2nd: @HDAXtx
* 3rd: Vope Medical
* Therapeutics focus award: @HDAXtx
* People’s choice: @vope_ai
Thank you @SweetPharmaDay for amazing sessions today, and honored to have been named 2021 best presentation at this invitation-only life sciences event!
We are proud to announce the winner of @SweetPharmaDay 2021. Congratulations to Nabanita Nawar from HDAX Therapeutics for your great presentation!
HDAX receives $2500 and memberships to @BIO_Qc and @BIOTECanada
Very excited that our #HDAX Therapeutics team is a part of the @Lab2MarketCA (#L2M)Toronto Summer 2021 Cohort! Wishing them all the best as they set off on their entrepreneurial journey towards research commercialization!
@MitacsCanada#HDAXTx#startup#innovation
At #MedicinebyDesign’s Building a Biotech Venture Pitch Competition, HDAX Therapeutics (@Patrick_Gunning lab) was chosen to receive $25,000 in funding for their #regenmed concept, a small molecule therapy that could have an impact on Alzheimer's disease ➡️https://t.co/8tiLCkdpk4